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Abstract.  The activity of cyclin-dependent kinases 
(cdl~) depends on the phosphorylation of a residue 
corresponding to threonine 161  in human p34  ~c2. One 
enzyme responsible for phosphorylating this critical 
residue has recently been purified from Xenopus and 
starfish. It was termed CAK (for cdk-activating _ki- 
nase), and it was shown to contain p40  M°15 as its cata- 
lytic subunit. In view of the cardinal role of cdks in 
cell cycle control, it is important to learn if and how 
CAK activity is regulated during the somatic cell cy- 
cle. Here, we report a molecular characterization of a 
human p40  M°15 homologue and its associated CAK ac- 
tivity.  We have cloned and sequenced a cDNA coding 
for human p40  M°tS, and raised specific polyclonal and 
monoclonal antibodies against the corresponding pro- 
tein expressed in Escherichia  coll.  These tools were 
then used to demonstrate that p40  M°~5 protein expres- 
sion and CAK activity are constant throughout the 
somatic cell cycle. Gel filtration suggests that active 
CAK is a multiprotein complex, and immunoprecipita- 
tion experiments identify two polypeptides of 34 and 
32 kD as likely complex partners of p40  u°15. The as- 
sociation of the three proteins is near stoichiometric 
and invariant throughout the cell cycle. Immunocyto- 
chemistry and biochemical enucleation experiments 
both demonstrate that p40  u°15 is nuclear at all stages 
of the cell cycle (except for mitosis, when the protein 
redistributes throughout the cell), although the 
p34cdc2/cyclin B complex, one of the major purported 
substrates of CAK, occurs in the cytoplasm until 
shortly before mitosis. The absence of obvious 
changes in CAK activity in exponentially growing cells 
constitutes a surprise. It suggests  that the phosphoryla- 
tion state of threonine 161  in p34 ~c2 (and the corre- 
sponding residue in other cdks) may be regulated pri- 
marily by the availability of the cdk/cyclin substrates, 
and by phosphatase(s). 
T 
HE cell cycle in all eukaryotes is governed by cyclin- 
dependent protein kinases  (cdks) l (Pines and Hunter 
1991a; Meyerson et al.,  1992; Norbury and Nurse, 
1992; Nigg, 1993; van den Heuvel and Harlow, 1993). These 
kinases  are regulated by multiple  mechanisms, including 
phosphorylation-dephosphorylation  (For reviews see Fleig 
and  Gould,  1991; Clarke and Karsenti,  1991; Solomon, 
1993;  Draetta,  1993), and the binding  to other proteins, 
notably cyclin regulatory subunits (reviewed in Hunt, 1991; 
Sherr, 1993) and small inhibitory polypeptides (Xiong et al., 
1993; Serrano et al., 1993; Gu et al., 1993; Harper et al., 
1993; EI-Deiry et al., 1993; Polyak et al., 1994). The com- 
plex regulation imposed on cdks is likely to reflect the fact 
that orderly progression through the cell cycle requires the 
integration  of a multitude of positive and negative signals. 
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1. Abbreviations  used in this paper: cdk, cyclin-dependent protein kinase; 
PKA, cAMP-dependent protein kinase. 
These are thought to include signals relayed from extracellu- 
lar agents such as mitogenic hormones and growth factors, 
as well as signals generated by intracellular feedback mecha- 
nisms that monitor the quality of individual cell cycle events 
and their orderly succession (for review see Murray, 1992). 
The prototypic and best characterized member of the cdk 
family, p34cd% functions in association  with cyclins of the 
A and B subfamilies to trigger entry into mitosis. Consistent 
with its function as an inducer of M phase,  its activity in- 
creases sharply at the G2/M transition and drops abruptly as 
cells exit from M phase (reviewed in Murray and Kirschner, 
1989;  Mailer,  1991; Norbury and Nurse,  1992). Several 
phosphorylation  sites have been mapped within the p34  ~2 
molecule (Gould and Nurse,  1989; Gould et al., 1991; Krek 
and Nigg,  1991a, 1992; Russo et al.,  1992). In all species 
examined, p34  ~c2 is phosphorylated on tyrosine 15 (Tyrl5), 
a residue located within the ATP-binding site of the kinase, 
and multiple kinases (weel, mikl) and phosphatases  (cdc25, 
pyp3) acting on this residue have been characterized in sev- 
eral species (reviewed in Fleig and Gould, 1991; Labib and 
Nurse, 1993; Solomon, 1993). In both fission yeast and ver- 
tebrates,  dephosphorylation  of Tyrl5 represents  the rate- 
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(Gould and Nurse, 1989; Krek and Nigg, 1991b, Norbury et 
al.,  1991). It occurs in response to intracellular signalling 
pathways  that  monitor  the  completion  of DNA  replica- 
tion, thereby preventing the premature initiation of mitosis 
(Enoch and Nurse, 1991; Smythe and Newport, 1992).  The 
situation is somewhat different in budding yeast, where the 
temporal separation between DNA replication and certain 
aspects of mitosis is less distinct (Sorger and Murray, 1992; 
Amon et al., 1992). In vertebrates, additional phosphoryla- 
tion of threonine 14 (Thr14)  has been demonstrated (Krek 
and Nigg, 1991a; Norbury et al., 1991), and it is attractive 
to speculate that Thr14 may represent the sensor for a second 
checkpoint control pathway,  monitoring the completion of 
another, as yet unidentified physiological event. Thrl4 can 
be dephosphorylated by the same phosphatase (cdc25) that 
also acts on Tyr15  (Honda et al.,  1993;  Sebastian et al., 
1993), but the kinase responsible for its phosphorylation has 
not yet been identified. 
Not all phosphorylations occurring on p34  ~2 lead to in- 
activation of the kinase.  In particular, phosphorylation of 
Thr161 (Thr 167 in Schizosaccharomycespombe)  was shown 
to be positively required for the function of p34~2:  muta- 
tions of Thrl61 to nonphosphorylatable residues (except Glu) 
inactivate  p34  ~2  protein kinase and  interfere with cyclin 
binding (Gould et al., 1991; Ducommun et al., 1991; Solo- 
mon et al.,  1992;  Krek et al.,  1992a).  Furthermore, there 
is a  temporal correlation between the phosphorylation of 
Thrl61  in  p34  ~2  and  the  time  when  its  cyclin partners 
are synthesized (Krek and Nigg,  1991a),  and, conversely, 
dephosphorylation of Thrl61  occurs  concomitantly with 
p34  ~2  inactivation upon exit from mitosis (Lorca et al., 
1992).  Phosphorylation of a  corresponding residue is be- 
lieved to be required for the activity of other cdks (Gu et al., 
1992;  Kato et al.,  1994),  although this has not yet been 
directly demonstrated for all members of the family. Also, 
corresponding residues have been shown to be phosphory- 
lated in cAMP-dependent protein kinase (PKA) and in MAP 
kinases, and the recent x-ray crystallographic analyses of 
PKA (Knighton et al., 1991a, 1991b), cdk2 (De Bondt et al., 
1993), and MAP-kinase (Zhang et al., 1994) provide plausi- 
ble explanations for why attachment of a phosphate at this 
position may be critical for folding the various kinases in an 
active conformation (for reviews  see Taylor et al.,  1993; 
Morgan and De Bondt, 1994). Phosphorylation of this resi- 
due is considered to be essentially constitutive in the case of 
PKA (Taylor et al., 1993), but it clearly plays a key regula- 
tory role in the activation of the MAP kinase cascade (re- 
viewed in Pelech and Sanghera,  1992;  Ahn et al.,  1992; 
Nishida and Gotoh,  1993). 
Recently, a kinase able to phosphorylate Thrl61 in p34  ~2 
(and the corresponding residue in p33 cdu) has been iden- 
tified and termed CAK. Originally, CAK was meant to stand 
for cdc2-activating kinase (Solomon et al., 1992); however, 
as the same kinase phosphorylates also p33  o~ and perhaps 
other cdks, at least in vitro, it seems appropriate to interpret 
the term CAK in a broader sense (i.e., cdk-activating kinase; 
see also Poon et al., 1993).  CAK isolated from starfish and 
Xenopus (Fesquet et al., 1993; Poon et al., 1993;  Solomon 
et al., 1993) was shown to contain a 40-kD catalytic subunit 
that had previously been isolated under the designation MO15 
(Shuttleworth et al., 1990). Highly purified active CAK from 
starfish was found to contain a second polypeptide (Fesquet 
et al.,  1993),  but the identity of this potential regulatory 
subunit has not yet been elucidated. One of the key questions 
raised by the above findings is how the activity of CA/( is 
regulated during the somatic cell cycle. To address this issue, 
we have cloned a eDNA for a human homologue of Xenopus 
p40  M°lS, and we carded out a detailed analysis of p40U°t5/ 
CAK expression, activity, and subcellular localization in ex- 
ponentially growing human cells. Our results have implica- 
tions for both the temporal and the spatial regulation of cdk 
activities during the cell cycle. 
Materials and Methods 
Cloning and Sequencing of  a Human M015 cDNA 
106 plaque-forming  units from a  human placenta k  gtll cDNA library 
(Clontech Laboratories, Paio Alto, CA), were screened by DNA hybridiza- 
tion.  Plaques  were  transferred  to  nitrocellulose  filters  (Schleicber  & 
Schuell, Inc., Keena, NH) that were treated with 1.5 M NaCI, 0.5 M NaOH 
for 5 min, then with 1.5 M NaCl, 0.5 M Tris-HCl, pH 8.0, for 5 rain, and 
finally with 2x SSC for 5 min (1× SSC is 0.15 M NaC1 and 15 mM sodium 
citrate). Filters were baked at 80°C for 2 h and prehybridized  at 42°C for 
4 h in solution A (0.1 M Pipes, pH 7.0, 0.8 M NaCI, 0.1% N-lauroyl sarco- 
sine,  50%  formamide,  5x  Denhardt's solution,  and 200 #g/ml salmon 
sperm DNA  (lx  Denhardt's solution is 0.02%  bovine serum albumin, 
0.02%  Ficoll, and 0.02%  polyvinylpyrrolidone).  Filters were hybridized 
with 32p-labeled MO15-specific  probes (described below)  at 42°C over- 
night in solution A, 2x  Denhardt's solution,  100 /~g/ml salmon sperm 
DNA, and 10% dextran sulfate. After washing for 2x 15 rain at room tem- 
perature in 2× SSC and 0.1% SDS, and 4x  15 min at 50°C in 0.2x SSC, 
0.1% SDS, filters were exposed to autoradiography film (X-OMAT; East- 
man  Kodak  Co.,  Rochester,  NY).  Recombinant phages  from  positive 
plaques were purified and subjected to two additional rounds of  purification. 
A 198-bp partial human eDNA (originally  designated as HsPK31), en- 
coding a 66-amino acid polypeptide with 90.9% identity  to the p40  u°15 
protein kinase of Xenopus/aev/s (Shuttleworth et al., 1990), was originally 
isolated in the course of a PCR-based  search for potential human homo- 
logues of the NIMA protein kinase, a cell cycle regulator in A~pergillus nid- 
u/ans (Schultz and Nigg,  1993). To prepare a 32P-labeled probe for hybrid- 
ization, the 19g-bp insert of the partial MOI5 eDNA was excised from the 
original HsPK31  plasmid by digestion with PstI and KPOI. The fragment 
was  gel  isolated  and labeled with [~-32p]dATP using a  random-primed 
DNA labeling kit (Boehringer Mannheim Biocbemicals,  Indianapolis,  IN). 
Inserts were excised  from recombinant k phages by EcoRI digestion and 
subcloned into the EcoRI site of pBluescript II KS (Stratagene,  La Jolla, 
CA). Plasmid DNAs were prepared using a Wizard Miniprep kit (Promega 
Corp., Madison, WI). Nested deletion templates for sequence analysis were 
generated using the Erase-A-Base  kit (Promega Corp.). Double-stranded 
DNA sequencing was carried out for both strands by the dideoxynuclvotide 
method. 
For expression studies, we have also constructed an NH2 terminally myc 
epitope-tagged version of p40  M°15 in the eukaryotic  expression plasmid 
pRc/CMV (Invitrogen,  San Diego, CA). The protein produced by this pins- 
mid contains the peptide MEQKLISEEDLNMNF fused in frame to the ini- 
tiator methionine of p40MO15; thus, the anti-myc epitope mAb 9El0 (Evan 
et al.,  1985) could be used for its detection. In vitro translation of p40  M°15 
or  myc  epitope-tagged  p40  M°'5  (constructed in pBluescript;  Schmidt- 
Zachmann and Nigg,  1993), was performed by priming the coupled tran- 
scription-translation reticulocyte  lysate system (Promega Corp.) with the 
corresponding Bluescript plasmids,  as described by the manufacturer. 
Bacterial Expression of  Human MOI5 Protein and 
Production of  Anti-M015 Antibodies 
A  polyhistidine-tagged  MOI5  fusion protein  was  generated  using  the 
QIAexpress bacterial expression system (QIAGEN Inc., Chatsworth,  CA). 
The plasmid pQEll-MO15 was constructed by excising a 820-bp BamHI 
fragment from the Bluescript plasmid containing the human MO15 eDNA 
and subcloned into the pQE11 vector. The expressed protein (221 residues) 
contains a poly-His  tag fused to the 214-amino acid COOH terminus of 
p40  ~°15. The protein was expressed in F~cherichia coli strain M15[pREP4] 
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NaCl/liter). Recombinant protein was purified under denaturing conditions 
as described by the manufacturer (QIAGEN Inc.). Poly-His-tagged MO15 
protein was finally eluted in buffer E (8 M urea, 0.1 M NaH2PO4,  10 mM 
Tris-HCl, pH 4.5) and stored at -20°C. 
Rabbit antibodies against bacterially expressed MOI5 protein were pro- 
duced as follows: intramuscular injections were carried out every 4 wk with 
280 t~g of purified recombinant MO15 protein in buffer E emulsified  in 
Freund's adjuvant.  Complete adjuvant was used for the first injection, in- 
complete adjuvant for all subsequent injections.  The polyhistidine-tagged 
MO15 fusion protein was also used to raise mAbs in mouse,  as described 
previously  (Lukas  et al.,  1992).  The mAb MO-I.I  used throughout this 
study is an IgG2b. 
AJ~inity Purification of the Rabbit Polyclonal Antibody 
and Preparation of  lmmunoglobulin Beads 
For all experiments involving rabbit (R30) polyclonal  anti-MOl5 antibod- 
ies, these were affinity purified as described by Harlow and Lane (1988). 
Briefly, purified recombinant MO15 protein was  subjected  to polyacryl- 
amide gel electrophoresis, blotted onto a nitrocellulose membrane, and a 
nitrocellulose strip containing the MO15 protein was excised. After incuba- 
tion with R30 anti-MOl5 serum, this strip was extensively  washed with 
PBS. Immunoglobulins were eluted with 0.1 M glycine, pH 2.5, neutralized 
with an equal volume of I M Tris-HCl, pH 8.0, and stored at 4°C. For coup- 
ling of antibodies to a solid support, affinity-purified rabbit immunoglobu- 
lins or hybridoma supernatants were incubated for 2 h at 4°C with protein 
A or protein G-Sepharose, respectively, equilibrated in 0.5 M Tris-HC1, pH 
7.5. Immunoglobulin-protein  A/G-Sepharose beads were washed with PBS 
and stored at 4°C. 
GST-CDK2 Expression and Purification 
GST-cdk2 in pGEX-2T (Tsai et al., 1991) was a generous gift from T. Hunt 
(Imperial Cancer Research Fund, South Mimms, U.K.). After transforma- 
tion ofE. coli strain BL21(DE3),  600-ml cultures were grown to an OD60o 
of '~1. Then, production of the recombinant GST-cdk2 protein was induced 
with isopropyl-/~-D-thiogalactopyranoside  (0.1 raM), and cells were lysed 
4 h later with 35 ml of 50 mM Tris-HC1, pH 7.5, 2 mM EDTA, 1 mM DTT, 
1 mM PMSE 10 t~g/ml leupeptin, 10 pg/ml pepstatin, 10 #g/ml aprotinin, 
and 2 mg/ml lysozyme at 4°C for 15 min. The lysate was sonicated and cen- 
trifuged at 10,000 g for 30 min. The supernatant was incubated for 1 h on 
ice with 0.5 mi glutathione-Sepharose  4B (Pharmacia Fine Chemicals, Pis- 
caraway, NJ), equilibrated in buffer G (buffer G =  PBS supplemented with 
0.25 M KCI, 0.1% Tween-20, 1 mM DTT, I mM PMSE 10 ~g/ml leupeptin, 
10 t~g/ml pepstatin, and 10/~g/ml aprotinin). Then, the material was poured 
into a column, and the column was washed with 10 vol of buffer G, followed 
by 3 vol of PBS containing 1 mM DTT. Finally, GST-cdk2 was eluted with 
5 mM reduced glutathione (Sigma Immunochemicals, St.  Louis, MO) in 
50 mM Tris-HCl, pH 8.0, 1 mM DTT. 
Cell Culture and Metabolic Labeling 
HeLa cells and the squamous carcinoma cell line UMSCC2 have been de- 
scribed previously (Krek and Nigg,  1991a; Palmero et al.,  1993). IMR90 
and WI38 diploid human lung fibroblasts  were obtained from American 
Type Culture Collection (Rockville,  MD). All cells were cultured at 37°C 
in a 7%  CO2 atmosphere in Dulbecco's  modified  Eagle's  medium,  sup- 
plemented with 5% (for HeLa) or 10% fetal bovine serum (for other cell 
types)  and  penicillin-streptomycin (GIBCO  BRL,  Gaithersburg,  MD). 
Where  indicated,  they  were  labeled  with  [3SS]methionine/[3SS]cysteine 
(Express35S35S; DuPont NEN, Regensdorf,  Switzerland) as described pre- 
viously (Krek and Nigg,  1991a). 
Immunoprecipitation of Human p40  u°zs 
and Kinase Assays 
Asynchronously growing HeLa cells were lysed in radioimmunoprecipita- 
tion assay buffer containing both protease and phosphntase inhibitors (50 
mM Tris-HC1; pH 8.0,!30 mM NaCI,  1% MP-40, 0.5% deoxycholate, 0.1% 
SDS,  1 mM PMSF, andlO t~g/ml each of leupeptin, pepstatin, aprotinin, 
and 20 mM NaF, 0.3 mM Na3VO4, 20 mM/3-glycerophosphnte). The ly- 
sates were incubated with immunoglobulin-protein A/G-Sepharose beads 
(prepared as described above) for 2 h at 4°C on a rotating wheel. Immune 
complexes  were washed four times with the above radioimmunoprecipita- 
tion assay buffer, twice with PBS, and once with kinase assay buffer (50 mM 
Tris-HCl, pH 7.5, 10 mM MgCI2,  1 mM DTT). 
Kinase assays were carried out in a total volume of 50 t~l of the above 
assay buffer, supplemented with 4 mM ATP, 10 t~Ci of [3,-32p]ATP (Amer- 
sham Corp., Arlington Heights,  IL), and 400 t~g/ml of purified GST-cdk2 
protein, as a substrate.  After 30 min at 32°C, the reaction was stopped with 
50 t~l of 3 ×  gel sample buffer. Phosphorylation of GST-cdk2 protein was 
analyzed by SDS-PAGE and autoradiography. 
Gel Filtration 
107 exponentially  growing HeLa cells were homogenized in 1 ml of NP-40 
buffer (1% NP-40 in 50 mM Tris-HC1, pH 8.0, 250 mM NaC1, 25 mM NaF, 
1 mM PMSF,  10/xg/ml each of leupeptin, pepstatin, and aprotinin, and 30 
/~g/ml each of DNaseI and RNase A). After centrifugation (14,000 g for 10 
min),  proteins  were  precipitated  with  70%  ammonium  sulfate  and 
resuspended in 1 ml of column buffer (50 mM Tris-HCl, pH 7.5, 250 mM 
NaC1, 0.5 mM EGTA,  10 mM MgCI2, 25 mM NaF). 200/~1 of the lysate 
was applied to a Superose  6 FPLC column (Pharmacia Fine Chemicals). 
This column had been equilibrated in the above column buffer at a flow rate 
of 0.2 ml/min and calibrated with 200 t~l of lysis buffer containing catalase 
(60 ~g),  aldolase (2 rag), ovalbumin  (2 rag),  and chymotrypsinogan A 
(0.5 nag). 
Miscellaneous Techniques 
HeLa cells were synchronized either by centrifugal elutriation (Draetta and 
Beach, 1988; Golsteyn et al.,  1994) or using drug arrest-release protocols 
(Krek and Nigg,  1991a). The procedures for immunoblotting, indirect im- 
munofluorescence  microscopy,  and enucleation have also been described 
previously  (Krek and  Nigg,  1991a,  1991b; Krek  et  al.,  1992b).  One- 
dimensional peptide mapping with V8 protease was carried out according 
to Cleveland (1983), and two-dimensional  tryptic phosphopeptide mapping 
and phosphoamino acid analysis was conducted according to Boyle et al. 
(1991). 
Results 
Cloning of  a Human MO15 cDNA and Identification of 
p40  M°15 in Different 7))pes of  Human Cells 
By screening a human placenta library with a PCR fragment 
isolated previously (originally termed HsPK31; Schultz and 
Nigg,  1993),  13  overlapping  cDNAs  coding  for  human 
p40  M°15 were isolated. The nucleotide sequence of the long- 
est cDNA (1,304 bp) and the corresponding translation prod- 
uct are shown in Fig. 1. The predicted human MO15 protein 
is composed of 346 amino acids, has an Mr of 39,123,  and 
displays  86%  identity with  p40  M°15 from Xenopus laevis 
(Fig.  1).  A  histidine-tagged  fragment  encompassing  the 
COOH-terminal 214 amino acids of p40  M°15 was expressed 
in E. coli, and the purified fusion protein was used to raise 
both polyclonal (rabbit) and monoclonal (mouse) antibodies. 
The specificity of these antibodies is illustrated in Fig. 2. As 
determined by immunoblotting, the R30 rabbit antibodies 
detected a single 40-kD protein in whole-cell extracts pre- 
pared from either human cancer-derived cell lines (HeLa 
and UMSCC2; Fig. 2, lanes 3 and 4) or cultures of nontrans- 
formed fibroblasts (IMR90 and WI38; Fig. 2, lanes 5 and 6). 
Interestingly, when  comparable  amounts of total protein 
were loaded in each lane (see the Coomassie blue staining 
profiles shown in Fig. 2, lanes 7-10), both cancer-derived 
cell  lines  expressed  three  to  five times higher  levels of 
p40  M°15 than the nontransformed cell types (Fig. 2, lanes 3 
and 4 vs lanes 5 and 6). The immunoreactive 40-kD protein 
comigrated exactly with the product obtained after in vitro 
translation of MO15 eDNA-derived RNA in a reticulocyte 
lysate (Fig. 2,  lane 2).  As expected, translation of a myc- 
Tassan et al.  Cell Cycle Regulation of Human p4OMO15/CAK  469 GGG  CGGGG  TTGGAGGCTTTAAGGTAG C  TTTAAATTCG  TG  TTG  TCCTGGG  AGCTCG  CCCTT 
TTCGG  CTC-G  AG  TCGGGCTTTACGGCGC CGGATGG  C  TCTGGACG  TGAAGTCTCGGGCAAAG 
HsMOI5  M  A  L  D  V  K  S  R  A  K  I0 
XIMOI5  M  •  •  I  A  A  R  G  V  -  I%  -  -  16 
CGTTATGAGAAGCTGGACTTCCTTGGGGAGGGACAGTTTGCCACCGTTTACAAGGCCAGA 
HsMOI5  R  Y  E  K  L  D  F  L  G  E  G  Q  F  A  T  V  Y  K  A  R  30 
XlMOI5  Q  ...................  36 
GATAAGAATACCAACCAAATTGTCGCCATTAAGAAAATCAAACTTGGACATAGATCAGAA 
HsMOI5  D  K  N  T  N  Q  I  V  A  I  K  K  I  K  b  G  H  R  S  E  50 
XIMOI5  -  -  D  R  ............  A  56 
GCTAAAGATGGTATAAATAGAACCGCCTTAAGAGAGATAAAATTATTACAGGAGCTAAGT 
HsM015  A  K  D  G  I  N  R  T  A  L  R  E  I  K  L  L  Q  E  L  S  70 
XIMOI5  -  N  ..................  76 
CATCCAAATATAATTGGTCTCCTTGATGCTTTTGGACATAAATCTAATATTAGCCTTGTC 
HsM015  H  P  N  I  I  G  L  L  D  A  F  G  H  K  S  N  I  S  L  V  90 
XIM015  ....................  96 
TTTG  A'FFi'~ATGGAAACTGATCTAGAGGTTATAATAAAGGATAATAGTCTTGTGC  TGACA 
HsMOI5  F  D  F  M  E  T  D  L  E  V  I  I  K  D  N  S  L  V  L  T  ii0 
XIMOI5  ..............  T  -  -  116 
CCATCACACATCAAAGCCTACATGTTGATGACTCTTCAAGGATTAGAATATTTACATCAA 
HSMOI5  P  S  H  I  K  A  Y  M  L  M  T  L  Q  G  b  E  Y  L  H  Q  130 
XIM015  -  A  -  S  .............  H  136 
CATTGGATCCTACATAGGGATCTGAAACCAAACAACTTGTTGCTAGATG  AAAATC-GAGTT 
HsMOI5  H  W  I  L  H  R  D  L  K  P  N  N  L  L  L  D  E  N  G  V  150 
XIM015  L  ...................  156 
CTAAAACTGGCAGATTTTGGCCTGGCCAAATCTTTTGGGAGCCCCAATAGAGCTTATACA 
HsMOI5  L  K  L  A  D  F  G  L  A  K  S  F  G  S  P  N  R  A  Y  T  170 
XIMOI5  .................  I  176 
CATCAGGTTGTAACCAGGTGGTATCGGGCCCCCGAGTTACTATTTGGAGCTAGGATGTAT 
HsMOI5  H  Q  V  V  T  R  W  Y  R  A  P  E  L  L  F  G  A  R  M  Y  190 
XIMOI5  .........  S  ..........  196 
GGTGTAGGTGTGGACATGTGGGCTGTTGGCTGTATATTAGCAGAGTTACTTCTAAGGGTT 
HsMOI5  G  V  G  V  D  M  W  A  V  G  C  I  L  A  E  L  L  L  R  V  210 
XIM015  ....................  216 
CC~'FFFFIGCCAGGAGATTCAGACCTTGATCAGCTAACAAGAATATTTGAAACTTTGGGC 
HsMOI5  P  F  L  P  G  D  S  D  L  D  Q  L  T  R  I  F  E  T  L  G  230 
XIMOI5  ....................  236 
ACACCAACTGAGGAACAGTGGCCGG  ACATG  TGTAG  TCTTCCAGATTATGTGACATTTAAG 
HsMOI5  T  P  T  E  E  Q  W  P  D  M  C  S  L  P  D  Y  V  T  F  K  250 
XIMOI5  ........  G  S  ......  A  -  256 
AGTTTCCCTGGAATACCTTTGCATCACATCTTCAGTGCAGCAGGAGACGACTTACTAGAT 
XIMOI5  S  F  P  G  I  P  L  H  H  I  F  S  A  A  G  D  D  L  L  D  270 
XIMOI5  -  -  T  -  L  -  I  .......  l  276 
CTCATACAAGGCTTATTCTTATTTAATCCATGTGCTCGAATTACGGCCACACAGGCACTG 
HsMOI5  L  I  Q  G  L  F  L  F  N  P  C  A  R  I  T  A  T  Q  A  L  290 
XIMOI5  -  L  -  T  ......  C  -  8  -  296 
AAAATGAAGTATTTCAGTAATCGGCCAGGGCCAACACCTGGATGTCAGCTGCCAAGACCA 
HsMOI5  K  M  K  Y  F  S  N  R  P  G  P  T  P  G  C  Q  L  P  R  P  310 
XIMOI5  R  K  R  ......  A  -  -  N  L  -  316 
AACTGTCCAGTGGAAACCTTAAAGGAGCAATCAAATCCAGCTTTGG  CAATAAAAAGGAAA 
HsMO15  N  C  P  V  E  T  L  K  E  Q  S  N  P  A  L  A  I  K  R  K  330 
XIMOI5  -  S  I  A  -  -  Q  -  L  N  G  -  -  336 
AGAACAGAGGCCTTAGAACAAGGAGGATTGCCCAAGAAACTAATTTTTTAAAGAGAACAC 
HsMOI5  R  T  E  A  L  E  Q  G  G  L  P  K  K  L  I  F  *  346 
XIMOI5  -  G  M  D  -  K  D  Z  A  -  S  *  352 
TGG  ACAACATTTTACTACTGAGGGAAATAGCCAAAAAGGCAAATAATGG  AAAAATAG  TAA 
ACATTAAGTAAATGCTGTAGAAGTGAGTTTGTAAATATTCTACACATGTAAAATATGTAA 
AACTATG  GG  TTA~'FI'±'I'ATTAAATG TATTTTAAAAAAAAAAAAA 
tagged MO15  RNA yielded a  slightly larger product of 42 
kD (lane/).  Several mAbs, e.g.,  MO-I.1  (Fig.  2,  lane 1/), 
were also found to be highly specific  for the 40-kD MO15 
protein. 
Expression of  p40  uo'J Is Invariant throughout the 
Somatic Cell Cycle 
To determine the steady-state  levels  of p40  M°~5 during the 
Figure 1.  eDNA  and  predicted  amino acid  se- 
quences  of human  p40  u°~s. The  human  MO15 
eDNA  contains  1304  nucleotides.  The  longest 
open reading frame (nucleotides  91-1229)  codes 
for a protein of 346 amino acids; the presence of 
an inframe stop codon upstream of the first ATG 
confirms that this open reading frame comprises 
the amino terminus of the MO15 protein. For com- 
parison, the p40  M°15 protein sequence from Xeno- 
pus/aev/s (Shuttleworth et al., 1990) is shown be- 
neath the human sequence. Note that no gaps were 
introduced in this alignment. Amino acids are in- 
dicated (in bold) only at positions where they di- 
verge;  identical  residues  are marked by dashes, 
and stop codons are indicated by stars. The human 
MO15 sequence has been submitted to the EMBL 
database  (accession number X79193).  Also,  we 
note that complete sequences for human CL20320) 
and mouse (X74145)  MOI5 have been deposited 
independently by other workers. 
cell  cycle,  HeLa  cells  were  synchronized  by  centrifugal 
elutriation  (Fig.  3).  Aliquots  of each  sample,  containing 
equal amounts of total protein, were then analyzed by immu- 
noblotting using antibodies  specific  for p40  uo'5.  For con- 
trol, the same samples were also probed with anti-cyclin A 
and anti-PSTAIRE  antibodies (a convenient tool to detect 
p34  ~a  and  other  cdk family  members;  Yamashita et  al., 
1991),  and a population of exponentially growing cells was 
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p40  Mot5 in different human cell types. Total cell lysates were pre- 
pared from exponentially growing HeLa and UMSCC2 carcinoma 
cells, as well as from two different types of diploid lung fibroblasts 
(IMR90  and  WI38).  Proteins  were  resolved  on  a  10%  SDS- 
polyacrylamide gel, and were either stained with Coomassie blue 
(lanes 7-10) or transferred to nitrocellulose and probed with R30 
anti-MO15 antibodies (lanes 3-6) or the monoclonal mouse anti- 
body MO-I.1 (lane//). Immunoreactive proteins were visualized 
by enhanced chemiluminescence (ECL), using appropriate second- 
ary antibodies coupled to horseradish peroxidase. For comparison, 
plasmids encoding either full-length MO15 protein (lane 2) or a 
myc-epitope-tagged p40  M°15 (lane 1 ) were subjected to coupled in 
vitro transcription-translation,  and the products of these reactions 
were analyzed in parallel, using the rabbit antibody for detection. 
Note that the only immtmoreactive protein present in total cell ly- 
sates comigrated exactly with in vitro-translated  p40MO~S; as ex- 
pected,  however, translation of the myc-epitope-tagged  p40  u°t5 
yielded a slightly larger product (lane 1 ). The positions of molecu- 
lar mass markers are indicated in kilodaltons. 
Figure 3.  Steady-state levels of p40  u°t5 are constant throughout 
the somatic cell cycle. HeLa  cells were sorted by centrifugal elutria- 
tion, exactly as described previously (Golsteyn et al.,  1994). For 
each cell population, one aliquot was used to determine its cell cy- 
cle position by FACS  ® analysis. Equal amounts of proteins were 
then resolved by gel electrophoresis and transferred to nitrocellu- 
lose. The same filter was probed with R30 anti-MO15 antibodies 
(top  panel), followed  by antibodies against cyclin A (Maridor et al., 
1993; middle  panel) and p34  ¢dc2 (anti-PSTAIRE; Yamashita et al., 
1991; bottom  panel). Note the typical appearance of differentially 
phosphorylated p34  ~2 proteins in the lanes containing G2 phase 
cells (arrows); also, longer exposures revealed the expected reac- 
tivity of anti-PSTAIRE antibodies with p33  cdk2 (not visible in this 
figure). The lane marked Exp represents an extract prepared from 
exponentially growing ceils; lanes 1-6 represent cells at progressive 
stages of the cell cycle. Below each lane, the contribution of G1, 
S, and G2/M phase cells is indicated in percentages. 
analyzed in parallel (lane marked Exp). For each sample, a 
FACS  ® analysis (Becton Dickinson Immunocytometry Sys- 
tems, Mountain View, CA) was carded out to determine the 
percentages of cells in G1, S, or G2/M phases (Fig. 3). Im- 
munoblotting with R30 anti-MO15 antibodies revealed that 
the level of p40  u°15 stayed constant throughout the cell cy- 
cle (Fig. 3, top panel; see also Fig. 5 A). The control experi- 
ments yielded the expected results: cyclin A (Fig. 3, middle 
panel) was virtually undetectable during the G1 phase (Fig. 
3, lanes I  and 2), but it accumulated as cells progressed to- 
wards S and G2 phases (Fig. 3, lanes 3-6); in contrast, the 
PSTAIRE-positive signal (Fig. 3, bottom panel) was essen- 
tially invariant throughout the cell cycle, except for the ap- 
pearance of a slower migrating PSTAIRE protein in S- and 
G2/M-phase cells, which is characteristic of tyrosine-phos- 
phorylated p34  ~'2 (Solomon et al.,  1992). 
p4Ouol~-associated  CAK Activity is Constant 
throughout the Cell Cycle 
To assay for CAK activity associated with p40  M°lS, the pro- 
tein  was  immunoprecipitated  from  asynchronous  HeLa 
cells, using either mAb MO-I.1 or the R30 rabbit anti-MO15 
antibody. After extensive washing, the immunoprecipitates 
were incubated with [3,-3~P]ATP and bacterially expressed 
GST-cdk2 as a substrate, as described by Poon et al. (1993). 
As shown in Fig. 4 A, GST-cdk2 was readily phosphorylated 
when incubated with either type of MO15 immunoprecipi- 
tate (Fig. 4, A, lanes 2 and 3), but not when exposed to mock 
immunoprecipitates carried out with protein G- or protein 
A-Sepharose beads, respectively (Fig. 4, A, lanes I  and 4). 
Tryptic  phosphopeptide  mapping  and  phosphoaminoacid 
analyses showed that GST-cdk2 was phosphorylated exclu- 
sively on threonine and on a single tryptic peptide (Fig. 4 B). 
These results are in full agreement with previous data show- 
ing that phosphorylation of GST-cdk2 by Xenopus  CAK oc- 
curs exclusively on threonine 160 (Poon et al.,  1993). 
Using  the  above  assay,  we  next  investigated  p40  M°lS- 
associated CAK activity in HeLa cells that had been syn- 
chronized at various stages of  the cell cycle. Cells were either 
arrested in mitosis using nocodazole, or at the G1/S bound- 
ary using aphidicoline, as described previously (Krek and 
Nigg,  1991a).  Then, they were released from these blocks 
for various lengths of time, and p40  M°15 was immunoprecip- 
itated.  For each sample,  the amount of p40  M°~5 recovered 
was determined by immunoblotting, and p40M°lS-associated 
CAK activity was assayed as described above. In parallel, 
aliquots of cells were used for FACS  ® analyses to determine 
the proportions of cells at different stages of the cell cycle. 
In a first experiment, cells were released for comparatively 
short time  intervals  from a  nocodazole-induced block in 
prometaphase (Fig. 5 A). Under these conditions, cells inac- 
tivate mitotic cdc2 kinase through destruction of B-type cy- 
clins and complete mitosis;  indeed, as assessed by micro- 
scopic  monitoring  of  cell  spreading  to  the  substratum, 
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single  threonine  residue.  (,4) p40  M°15 was  immtmoprecipitated 
from exponentially  growing HeLa ceils, using either mAb MO-I.I 
(lane 2 ) or the rabbit polyclonal antibody R30 (lane 3). For control, 
mock immunoprecipitations  were carried out using protein G beads 
(lane 1) or protein A beads (lane 4). Washed immune complexes 
were then assayed for kinase activity using GST-edk2 as a substrate, 
as described previously (Poon et al.,  1993).  (B) Phosphorylated 
GST-cdk2  protein (obtained as described in A) was subjected  to 
two-dimensional  tryptic phosphopeptide  mapping and  phospho- 
amino acid analysis (Boyle et al., 1991). O marks the site of sample 
application,  and the inset shows the result of  the phosphoamino acid 
analysis  (S,  phosphoserine;  T, phosphothreonine;  Y,  phospho- 
tyrosine). 
B  C 
Nocodazole  release  Aphidicolin  release 
v  0  I  6  I  12  I  18  I  24  I  0  I  6  I  12  I  18  I  24 
hours  hours 
%G1  8/4  59/72  57/7829/31  10135  51135 42/4  11518  64/58  79138 
%S  13117  15/5  34/18  60130 38110  36/46  55/46  74/9  25/14  17133 
%G2/M  79179 26•23  9/14  11141 52/55  13119 3/50  11/83  11128  4/29 
Figure 5. p40U°~5-associated CAK activity  is constant throughout 
the cell cycle. (A) HeLa cells were arrested in prometaphase with 
nocodazole. Before release from the nocodazole block (0) or at the 
indicated  time intervals after the release,  p40  u°t5 was immunopre- 
cipitated  from equal  numbers of cells,  using mAb MO-I.1.  Each 
sample was assayed for CAK activity, using GST-cdk2 as a substrate 
(upper part), and recovery of p40  u°15 was controlled by immuno- 
blotting using the R30 antibody (lower part ). (B) HeLa cells were 
arrested either in prometaphase with nocodazole, or at the G1/S 
boundary with aphidicolin,  exactly as described previously (Krek 
and Nigg,  1991a). Before release from these blocks, or at the indi- 
cated time intervals after the release,  p40  u°~5 was immunoprecipi- 
rated and its recovery and associated CAK activity were determined 
as described above (A). In parallel,  aliquots  of each sample  were 
subjected  to FACS  ® analyses.  The specific  CAK activities  (i.e., 
phosphate  incorporation into GST-cdk2,  relative  to the amounts 
p40  M°~ protein  present in the immune complexes)  were then de- 
termined by densitometric scanning of the data, and results  from 
two independent experiments are shown in the form of  a histogram. 
Below, the results of  the FACS  ®  analyses are summarized: numbers 
to the left refer to experiment  1 (hatched bars), numbers to the fight 
to experiment  2 (open bars). 
daughter  cells  reentered  G1  phase  by  "~4-6  h  (data  not 
shown). Fig. 5 A illustrates that the level of p40  M°15, as well 
as its associated CAK activity, remained virtually constant 
through mitosis and reentry into the subsequent G1 phase. 
Fig. 5, B and C, summarize the results obtained when simi- 
lar  drug-arrest/release  experiments,  using  aphidicolin  and 
nocodazole,  respectively,  were carried  out over the  entire 
cell cycle. Again, the specific activity of p40M°lS-associated 
CAK was constant at all stages of  the cell cycle. Yet, previous 
studies based on a virtually identical experimental approach 
had revealed striking cell cycle-dependent changes in the ac- 
Figure 6. Gel filtration suggests the existence ofa multiprotein  CAK 
complex.  A lysate (200 #1) was prepared from exponentially  grow- 
ing HeLa cells  (see Materials  and Methods) and applied  to a Su- 
perose 6 FPLC column (Pharmacia Fine Chemicals).  500-~1 frac- 
tions were collected,  and  120 t~l of each fraction were used  to 
determine the abundance of p40  M°tS, using mAb MO-I.1  for im- 
munoblotting (upper panel).  The remainder of each sample was 
subjected  to immunoprecipitation with MO-I.1,  and CAK activity 
was monitored with GST-cdk2 as a substrate (lower  panel). Vertical 
bars mark the elution of molecular mass markers,  catalase (232 
kD), aldolase (158 kD), ovalbumin (43 kD), and chymotrypsinogen 
A (25 kD), used for calibration  of the column. 
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(A) Exponentially growing HeLa cells were labeled for 16 h with 
[3SS]methionine/cysteine (50/zCi/ml),  and then 1>40  M°l~ was im- 
munoprecipitated using either rabbit antibody P,30 (lane 3) or mAb 
MO-I.I (lane 4). Note that two proteins of 34 and 32 kD (p34 and 
p32)  coimmunoprecipitate  specifically  with  p40  M°t5 (arrows); a 
third  protein  of 57 kD (arrowhead) was also coprecipitated,  but 
recovery of this protein was variable.  For controls,  the migration 
of in vitro-translated p40  M°15 is shown in lane 1, and the extent of 
nonspecific  protein  binding  to beads is illustrated  by mock im- 
munoprecipitations using protein A-Sepharose (lane 2) and protein 
G Sepharose (lane 5). The positions of  molecular mass markers are 
indicated in ldlodaltons.  (B, lanes 1 and 2) An immune complex 
of p40  M°t5 obtained  with  MO-I.I antibodies  (lane  1) was boiled 
for 7 min in 100 t~l of 50 mM Tris-HCl, pH 8.0, 1% SDS,and I mM 
DTT. RIPA buffer conditions were then reconstituted by appropri- 
ate addition of detergents and salts to a final volume of 1 ml, and 
the  sample was subjected to a second immunoprecipitation  with 
MO-I.1 antibodies (lane 2). Note that boiling disrupted  the com- 
plex between p40  u°~ and its putative partners.  (Lane 3) Coomas- 
sie  blue  staining  of an  immunoprecipitate  obtained  with  mAb 
MO-I.1 from ~4  x  106 cells. Note that p40  M°~5, p34, and p32 are 
recovered in a ratio of *1:1:1, and that the identity of p40 M°~5 was 
confirmed by microsequencing (data not shown). Arrowheads indi- 
cate  immunoglobulin  heavy  (HC)  and  light  chains  (LC).  (C) 
p40  M°15 immunoprecipitations  were carried  out from 35S-labeled 
HeLa (lane 3), UMSCC2 (lane 4), IMRg0 (lane 5), and WI38 cells 
(lane 6), as described above (A). For control,  the migration of in 
vitro-translated p40  M°ls is shown in lane 1, and a HeLa cell lysate 
was treated with protein G Sepharose only (lane 2). To facilitate 
the comparison of complexes between p40  M°15 and p34/p32 in the 
different cell types, sample loadings for transformed and untrans- 
formed cells were adjusted to yield comparable levels of p40 M°ls. 
(D)  p40  M°lS, p34,  and  p32  were  subjected  to  one-dimensional 
tivity of p34  cd¢2 (Krek and Nigg,  1991a).  We are forced to 
conclude from these results that progression through the so- 
matic cell cycle is not accompanied by any major changes in 
p40Mols-associated  CAK activity, at least as assayed in im- 
munoprecipitates (see Discussion). In this context, we note 
also that p40  M°15 is a phosphoprotein in vivo (Tassan, J.-P., 
and E. A. Nigg, unpublished results). Yet, CAK activity as- 
sociated  with  p40  M°~5 immunoprecipitates  was  unaffected 
by the presence or absence of phosphatase inhibitors in lysis 
and washing buffers (data not shown). 
Idenfffication of Two Candidate Complex Partners 
of  p40  M°~ 
In starfish and Xenopus  eggs, p40  M°~5 appears to associate 
with  other proteins  to  form active  CAK  (Fesquet  et  al., 
1993;  Poon  et  al.,  1993).  To determine  whether  p40  M°t5 
forms complexes with other proteins in somatic cells, a gel 
filtration experiment was carried out  (Fig.  6).  HeLa cells 
were lysed in the presence of NP-40 detergent, and proteins 
were size fractionated on a Superose 6 column. Then, each 
fraction  was  subjected  to  immunoprecipitation  with  anti- 
MO15 antibodies, and immunoprecipitates were probed by 
immunoblotting for the abundance of p40  M°15 (Fig. 6, upper 
panel). In parallel, they were assayed for CAK activity, us- 
ing GST-cdk2 as a substrate (Fig. 6, lower panel). This ex- 
periment shows that the bulk of p40  u°ls  did not occur as a 
monomer but, instead, migrated in complexes with an appar- 
ent molecular mass of "~60-120 kD. Interestingly, the CAK 
activity of each fraction paralleled the abundance of p40  M°tS, 
indicating that, at least under the lysis conditions used here, 
the bulk of the p40M°~5-associated  kinase was recovered in 
an active state. 
To search for cellular proteins that might specifically as- 
sociate  with  p40  M°tS,  immunoprecipitation  experiments 
were carried out. As shown in Fig. 7 A, both polyclonal (lane 
3) and monoclonal (lane 4) anti-MO15 antibodies specifically 
precipitated two polypeptides with molecular masses of 34 
and 32 kD, in addition to p40  Mo~s. A  third protein of ,o57 
kD was also precipitated, particularly when using the rabbit 
anti-MO15 antibodies (Fig. 7 A, lane 3; arrowhead); how- 
ever, recovery of this 57-kD protein was variable (Fig. 7, A 
vs B), and its identity has not been further investigated. Im- 
portantly, none of these proteins was precipitated by protein 
A- or protein G-Sepharose (Fig. 7 A, lanes 2 and 5). Also, 
when immune complexes were boiled and then subjected to 
a  second immunoprecipitation with anti-MO15  antibodies, 
only p40  M°~5 was  recovered (Fig.  7  B,  lane 2  vs  lane  1). 
This indicates that none of the coprecipitating proteins were 
recognized directly by anti-MO15 antibodies. 
As indicated by peptide mapping with V8 protease, the 34- 
and 32-kD proteins appear to be structurally distinct from 
each other,  as  well as  from p40  M°15 (Fig.  7  D).  Also,  the 
34/32-kD  proteins  were not  recognized by anti-PSTAIRE 
antibodies, indicating that they are not identical with p34  ~d~2 
or p33  °du (data not shown), a conclusion supported further 
by microsequence analysis (Tassan, J.-P., S. Frutiger, G. J. 
Hughes, and E.  A.  Nigg, unpublished results).  Complexes 
peptide mapping (Cleveland, 1983) using increasing amounts of V8 
protease  as indicated.  Digestion products were analyzed by elec- 
trophoresis  on a  15% SDS-polyacrylamide  gel. 
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proteins  coimmunoprecipitate in  similarly  large  amounts 
and may, thus,  form a  near-stoichiometric complex. 
To  determine  whether  p40  ~°~s might  undergo  cell  cy- 
cle-dependent complex formation, immunoprecipitation ex- 
periments were carried out from HeLa cells that had been 
synchronized by drug-arrest/release protocols and pulse la- 
beled  with  [35S]methionine/cysteine at  different stages  of 
the cell cycle (Krek and Nigg,  1991a).  As shown in Fig. 8, 
no  significant cell cycle-dependent changes  could be  de- 
tected in either the accumulated levels of p40  ~°15 or its as- 
sociation with the 34/32-kD proteins. 
Figure 8. Association of p40  M°~5 with p34/p32 is constant during 
the cell cycle. Immunoprecipitations with rabbit R30 anti-MO15 
antibodies were carried out from HeLa cells that had been labeled 
for 4 h with [ssS]methionine/cysteine  (100 #Ci/ml).  Lysates were 
prepared from cells representing progressive stages of  the cell cycle 
(Krek and Nigg, 1991a). Lanes 2 and 3, Exponentially growing 
cells (lane 2 shows a protein A-Sepharose mock immunoprecipita- 
tion for control); lane 4, cells predominantly in G1 phase (5 h after 
a release from a nocodazole block in prometaphase); lane 5, cells 
at G1/S phase (arrested with aphidicolin); lane 6, cells in S and G2 
phase (5 h after release from the aphidicolin block); lane 7, cells 
in M phase (arrested with nocodazole). The contribution of G1, S, 
and G2/M phase cells to each population was determined by FACS  ® 
analysis (using duplicate plates), and the results are indicated below 
each lane. 
between t>40  M°t5 and the  34/32-kD polypeptides could be 
detected, not only in HeLa cells, but also in UMSCC2 carci- 
noma ceils, and in two different types of nonimmortalized 
human fibroblasts (Fig. 7  C).  Remarkably, p40  M°~5 and its 
putative 34/32-kD complex partners could be stained readily 
Human p40  M°15 Protein Localizes to the Cell Nucleus 
Indirect immunofluorescence microscopy was used to exam- 
ined the subcellular localization of p40  M°~s (Fig.  9).  After 
incubation with R30 anti-MO15 antibodies, interphase HeLa 
ceils displayed a  strong staining of nuclei, with negligible 
staining  of the  cytoplasm (Fig.  9,  a, f,  and g).  Uniform 
results were obtained for all cells in exponentially growing 
cultures,  indicating  that  p40  M°ts  does  not  undergo  any 
significant redistributions during interphase of the cell cycle. 
In mitotic cells, p40  M°~5 was diffusely distributed, with no 
evidence for a  specific association with  either condensed 
chromosomes or spindle microtubules (Fig. 9, c and  f). Vir- 
tually identical results were obtained when analyzing nonim- 
mortalized IMR90  human  fibroblasts (Fig.  9  h)  or when 
using monoclonal antibodies for detection of p40  M°l~ (Fig. 
9  f).  Also,  results  were  indistinguishable  regardless  of 
whether ceils were fixed and permeabilized using parafor- 
maldehyde detergent (Fig. 9, a, g, and h) or organic solvents 
(Fig.  9 f).  Finally,  when  HeLa were transfected with  a 
cDNA encoding a myc epitope-tagged version of p40  M°~5, 
anti-myc epitope antibodies also stained the nuclei of trans- 
fected ceils, indicating that the exogenously expressed MO15 
protein localized to the same compartment as endogenous 
p40  M°15 (Fig. 9  i). 
Figure 9.  Immunofluorescent 
localization  of p40  M°15. En- 
dogenous p40  ~°t5 was visual- 
ized by indirect immunofluo- 
rescence  microscopy,  using 
either R30 antibodies (a, c, f, 
and g)  or mAb MO-I.1 (h). 
Both HeLa (a-e, f, and h) and 
IMR90  cells  (g) were exam- 
ined.  Fixation-permeabiliza- 
tion  was  achieved using ei- 
ther paraformaldehyde-Trit  on 
X-100 (a-e and g-i) or meth- 
anol/acetone  (f),  with virtu- 
ally identical results. Finally, 
HeLa cells  were  transiently 
transfected with apCMV plas- 
mid coding for a myc-epitope- 
tagged p40  M°lS, and the sub- 
cellular  localization  of  the 
ectopically expressed protein 
was visualized using the anti- 
myc tag mAb 9El0 (i; arrowheads indicate untransfected ceils). Note the exclusive nuclear localization of p40  M°15 in interphase cells (a 
vs b; phase contrast). In mitotic cells (c-e), p40  M°15 was diffusely distributed and showed no obvious association with condensed chromo- 
somes (d; DNA staining with Hoechst 33258; e; phase contrast).  Bar in a,  10/~m. 
The Journal of Cell Biology,  Volume 127, 1994  474 Figure 10.  Localization of p40  M°js by subcellular fractionation. 
Exponentially growing HeLa ceils were enucleated as described 
previously for chicken DU249 cells (Krek et al., 1992b; Hermekes 
et al., 1993). Nuclear (N) and cytoplasmic (C) fractions, as well 
as total cellular lysates (T), were then analyzed by immunoblotting 
using antibodies against p40  M°~5. In parallel, appropriate antibod- 
ies were used to monitor the partitioning of lamin B2 (a marker 
for the nucleus) and tubulin (a marker for the cytoplasm). 
To corroborate these immunocytochemical results by in- 
dependent biochemical evidence, enucleation experiments 
were carried out. HeLa ceils were grown on round coverslips 
and then fractionated by centrifugation in the presence of 
cytochalasin D (Krek et al., 1992b; Hennekes et al., 1993). 
This procedure yields nuclei with some contamination by 
cytoplasm, and cytoplasts with a minimal contamination by 
intact cells (Gordon et al.,  1981; Banerle and Baltimore, 
1988).  After separation of nuclei and cytoplasts, the parti- 
tioning of p40  M°ls was examined by immunoblotting. For 
control, the distributions of a  nuclear marker  (lamin Bz) 
and a cytoplasmic marker (tubulin) were assayed in parallel. 
As shown in Fig.  10 (upper panel),  p40  M°lS was recovered 
almost exclusively from the nuclear fraction; the minimal 
amount of p40  M°~s detectable in cytoplasts (9%) can readily 
be attributed to contamination by intact cells because a simi- 
lar proportion (7 %) of nuclear lamin was also detectable in 
the cytoplasts (Fig.  10, middle panel).  Conversely, tubulin 
was present predominantly in the cytoplasts, as expected 
(Fig. 10, lower  panel). Based on the results of  both immuno- 
cytochemistry  and  biochemical  analysis  of  fractionated 
ceils, we thus conclude that at all interphase stages of  the cell 
cycle p40  M°~5 is a predominantly nuclear protein. 
Discussion 
The p34  ~2 protein kinase and structurally related cdks play 
a pivotal role in promoting cell cycle progression in all eu- 
karyotes. In addition to cell cycle-dependent changes in the 
subunit composition of cdk/cyclin complexes, the reversible 
phosphorylation of p34  ~2 and the other cdks has been rec- 
ognized as a major mechanism for regulating their activities 
(for references see Introduction). Since the phosphorylation 
state of cdks appears  to be controlled by external signals 
and/or internal checkpoint controls, it is important to iden- 
tify the kinases and phosphatases acting on cdks, and to de- 
termine how their activities are integrated with intracellular 
signal transduction pathways. Important progress in this field 
has been made recently with the identification of p40  M°t~ as 
the catalytic subunit of CAK, the enzyme responsible for 
phosphorylating p34  ~2  on Thrl61  (Fesquet et al.,  1993; 
Pooh et al.,  1993;  Solomon et al.,  1993).  This enzyme is 
also  able  to  phosphorylate  a  corresponding  residue  in 
p33  ~u  and possibly  in  other  cdks,  but its precise  target 
range has not yet been determined (for reviews see Draetta, 
1993;  Solomon, 1994). 
In this study, we describe a molecular characterization and 
cell cycle analysis of human p40M°tVCAK. We have cloned, 
from a human placenta library, a cDNA coding for a 40-kD 
protein that displays 86% sequence identity to p40  M°~5 from 
Xenopus laevis. Independently, partial cDNAs  for human 
and mouse p40  M°t5 have been isolated in other laboratories 
(Ershler et al., 1993; Canoe et al., 1993).  Using a CAK as- 
say described by Pooh et al. (1993), we further show that an- 
tibodies raised against bacterially expressed human p40  Mot5 
readily immunoprecipitate CAK activity from cultured hu- 
man cells. From these results, we conclude that we have iso- 
lated a  functional homologue of the Xenopus MOI5 gene. 
Highly specific poly- and monoclonal antibodies were then 
used to study the expression and subcellular localization of 
t>40  u°~5, as well as the activity and subunit composition of 
CAK, during the human somatic cell cycle. 
Perhaps the most unexpected result of the present study is 
that no cell cycle-dependent changes could be detected in ei- 
ther the expression of MO15 protein or its associated CAK 
activity. Previous studies had failed to reveal any significant 
variations in CAK activity during the early embryonic devel- 
opment ofXenopus laevis (Solomon et al., 1992; Poon et al., 
1993).  However, because cell growth is uncoupled from cell 
division in these early cleavage embryos, the embryonic cell 
cycles lack bonafide G1  and G2 phases, and at least some 
checlq~int controls are not operational (for review see Mur- 
ray and Hunt, 1993).  It was clearly important, therefore, to 
study the expression and regulation of CAK activity during 
progression through a somatic cell cycle. On the basis of the 
results obtained here and results obtained independently by 
Pooh and colleagues (1994),  it is difficult to escape the con- 
clusion that CAK activity is constant not only in early em- 
bryonic cell cycles, but also in exponentially growing so- 
matic cells.  This  conclusion,  however,  is  subject to  one 
important caveat: it is virtually impossible to exclude the pos- 
sibility that p40  M°t5 might be regulated within living cells 
by rapidly reversible posttranslational modifications, or by 
labile interactions with other proteins. Such modifications  or 
weakly interacting proteins might  be lost during immunopre- 
cipitation of p40  M°tS, and changes in CAK activity might 
thus go undetected in standard in vitro assays. In spite of this 
caveat,  however,  the  available evidence suggests  that the 
phosphorylation state of Thrl61 in p34  ~2 (and of the corre- 
sponding residues in other cdks) may be regulated primarily, 
and perhaps exclusively,  at the level of the substrate and/or 
the corresponding phosphatase(s). This implies that cdks are 
likely to be phosphorylated by a constitutively active CAK 
as soon as they become available in a suitable conformation. 
We emphasize that our study focused on CAK activity in 
exponentially growing cells. We have not described results 
on CAK expression or activity in Go arrested cells, but Poon 
et  al.  (1994)  recently  found that  p40  M°~s is  absent  from 
serum-starved mouse 3T3  cells.  This  result is  not unex- 
pected, and it falls in line with the observation that cdk-cyclin 
complexes, the targets of CAK, are themselves absent from 
Go-arrested cells (e.g., Lee et al., 1988; Matsushime et al., 
1994). Also, we emphasize that the results described here do 
not exclude that CAK may be responsive to external growth 
regulatory signals, or to internal checkpoint controls monl- 
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do strongly indicate that CAK activity is not subject to regu- 
lation as part of a program intrinsic to every cell cycle. 
Immunoffuorescence microscopy, as well as biochemical 
fractionation experiments, unequivocally demonstrate that 
p40  uo~ is nuclear throughout interphase of the cell cycle. 
This  result  also  constitutes a  surprise.  Although several 
potential targets of CAK do occur within the nucleus, e.g., 
the complexes between cdks and cyclin A (Pines and Hunter, 
1991b; Girard et al., 1991; Pagano et al., 1992; Zindy et al., 
1992; Maridor et al., 1993), cyclin D1 (Baldin et al., 1993), 
or cyclin E  (Lehner, C. E, personal communication), the 
virtually exclusive nuclear localization of p40  u°~5 is diffi- 
cult to reconcile with the cytoplasmic localization of some 
of the purported CAK substrates, notably the p34~cVcyclin 
B complexes (Pines and Hunter,  1991b; Gallant and Nigg, 
1992; Ookata et al:, 1992).  These complexes are presumed 
to be phosphorylated in the cytoplasm, before they translo- 
cate to the nucleus at the onset of mitosis. To resolve this ap- 
parent paradox,  one has to argue that either cytoplasmic 
cdk/cyclin complexes are substrates for CAKs containing as 
yet unidentified catalytic subunits distinct from p40  M°'5, or, 
alternatively, that some of the protein complexes must cross 
the nuclear envelope. Considering that nucleocytoplasmic 
interactions are much more dynamic than suggested by the 
analyses of steady-state protein distributions (for discussion 
see  Nigg,  1992),  it  is  possible  that  p40~°~VCAK or 
p34~2/cyclin B complexes, or both, might shuttle between 
nucleus and cytoplasm (Schmidt-Zachmann et al.,  1993). 
Furthermore, considering that p34  ~c2 occurs in excess over 
cyclins,  it  is  attractive  to  speculate  that  p34  cdc2 protein 
might be phosphorylated by CAK within the nucleus, and 
then be captured by a B-type cyclin after its diffusion to the 
cytoplasm. It appears doubtful that free monomeric p34  ca2 
could  efficiently be  phosphorylated  by  CAK  (Solomon, 
1994), but one could invoke a model in which a chaperone- 
like protein might bind to nuclear p34  ¢ac2, thereby confer- 
ring a conformation appropriate for the phosphorylation of 
Thrl61. The fact that a GST-cdk2 fusion protein can readily 
serve as a  substrate for CAK (Poon et al.,  1993, and this 
study) illustrates that cdk phosphorylation can occur in the 
absence of cyclin binding. Perhaps the GST fusion moiety 
confers to cdk2 a conformation that would normally result 
from the binding of a cyclin or a (hypothetical) chaperone. 
Previous work strongly suggests  that the starfish oocyte 
MO15  protein may form a  stoichiometric complex with a 
second, somewhat larger polypeptide (Fesquet et al., 1993). 
Although no information has yet been reported on the molec- 
ular identity of  this putative regulatory subunit, there is addi- 
tional evidence to support the idea that CA/( may be a mul- 
tiprotein complex.  Gel  filtration of starfish and Xenopus 
oocyte extracts revealed two complexes containing MO15 
protein, only one of which, migrating at 180-220 kD, dis- 
played the bulk of the CAK activity (Solomon et al.,  1992; 
Poon  et  al.,  1993).  Also,  bacterially expressed Xenopus 
MO15 protein was reported to be inactive unless it was in- 
cubated with cellular extracts, suggesting that either binding 
of another protein  or  a  posttranslational modification of 
p40  M°" was  required  for  kinase  activation  (Poon  et  al., 
1993).  Given the structural similarity between p40  M°~5 and 
cdks (Shuttleworth et al.,  1990),  it is tempting to speculate 
that p40  M°t5 might require a  cyclin-like partner.  It is per- 
haps significant,  therefore,  that the closest relative of p40  u°15 
in S. cerevisiae,  the product of the KIN28 gene, has recently 
been shown to associate with a cyclin-like protein (Valay et 
al.,  1993).  However,  as yet, there is no direct evidence for 
a  functional homology between the KIN28 and the MO15 
gene products. 
In this study, we provide evidence for the existence of a 
CAK multiprotein complex in somatic human cells. As de- 
termined by fractionation on a  Superose  6  column, both 
p40  M°15 protein and CAK activity eluted as a  broad peak 
with an apparent molecular mass of ,~60-120 kD. In direct 
support of a multiprotein CAK complex, immunoprecipita- 
tion of p40  M°15 from human cells allowed the identification 
of two potential complex partners. Using two different anti- 
body preparations, two proteins of 34 and 32 kD were found 
to coimmunoprecipitate invariably with p40  M°~5 and CAK 
activity from all cell types analyzed and at all stages of the 
cell cycle. Binding of these proteins to p40  M°~5 appeared to 
be of high affinity because the complexes remained intact in 
the presence of mixed detergents (1% NP-40,  0.5 % deoxy- 
cholate, 0.1% SDS;  see Fig.  7),  as well as in high ionic 
strength solutions (2 M NaCI; Tassan, J.-P., and E. A. Nigg, 
unpublished results). Furthermore, all three coimmunopre- 
cipitated  proteins  could  readily be  visualized  in  similar 
quantities by Coomassie blue staining, indicating that they 
may form a heterotrimeric complex. Alternatively, it is pos- 
sible that our antibodies immunoprecipitate a mixture of sev- 
eral  complexes;  one  such  complex  might  then  contain 
p40  M°~5 and only the  34-kD  protein,  another p40  M°~s as- 
sociated only with the 32-kD protein. Whatever the precise 
stoichiometry of these complexes, we note that human CAK 
is abundant in somatic cells, unlike CAK in Xenopus eggs 
(Solomon et al.,  1993):  on the basis of partial purification 
experiments, we estimate that p40  M°t5 and its two putative 
complex partners may each be present at ~1-5  x  1@ cop- 
ies per HeLa cell, and at only three to five times lower levels 
in nontransformed human fibroblasts. 
At present, we have no definitive information on the mo- 
lecular identity of the 34- and 32-kD proteins. Preliminary 
results  from  microsequence  analyses did  not  reveal  any 
significant similarities to protein sequences presently avail- 
able in databases, but they confirm that the two proteins are 
distinct from each other and from p40  ~°t5 (Tassan, J.-P.,  S. 
Frutiger,  G.  J.  Hughes,  and E.  A.  Nigg, unpublished re- 
suits).  Also, we note that the two proteins identified here 
differ in molecular weight from the single putative MO15 
complex partner purified from starfish oocytes (Fesquet et 
al., 1993).  Clearly, the molecular cloning of these putative 
p40  Mo15 partners will be indispensable for a better under- 
standing of CAK function in different cell types. 
Note Added in  Proof  The 34-kD complex partner of p40  M°ls has now 
been identified as a cyclin-like pi'otein termed cyclin H (M~ikel~i, T. P., 
J.-P. Tassan, E. A. Nigg, S. Frutiger, G. J. Hughes, and R. A. Weinberg. 
1994.  A novel cyclin-associating with the CDK-acti~'atlng kinase MO15. 
Na  tu re (Lond.).  In press; Fisher, R. P., aiid D .:  (~-/~o'r~afi. 1994: :A novel 
cyclin associates with MO15/CDK7 to form the CDK-activating kinase. 
Cell.  78:713-724.). 
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